Observational studyBritish journal of haematology2026

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

Andrea Duminuco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.